Welcome to our dedicated page for Cosmos Health news (Ticker: COSM), a resource for investors and traders seeking the latest updates and insights on Cosmos Health stock.
Cosmos Health Inc. reports developments across a vertically integrated healthcare platform that includes wholesale pharmaceutical distribution, contract manufacturing, proprietary nutraceutical brands and research and development. Recurring updates cover U.S. commercialization of the 18 Series nutraceutical portfolio, including Noor18, Liv18, Cur18 and Fort18, as well as Sky Premium Life orders, international distribution relationships and product launches.
Company news also covers financial results, margin and revenue drivers at Cana Laboratories, CosmoFarm and Decahedron, AI investments including the Cloudscreen drug-repurposing platform, and Nasdaq listing-compliance or governance matters tied to its common stock.
On May 21, 2024, Cosmos Health received an additional delinquency letter from Nasdaq for failing to file its Form 10-Q for Q1 2024 and its Annual Report on Form 10-K for 2023.
The initial failure notice was issued on April 17, 2024, giving the company until June 17, 2024, to submit a plan to regain compliance. If Nasdaq accepts the plan, Cosmos Health could get an extension until October 14, 2024, to meet the compliance requirements. Failure to comply could result in delisting, but the company's shares remain listed for now.
CEO Greg Siokas expressed confidence in regaining compliance. The situation could impact investor confidence and stock performance (NASDAQ: COSM).
Cosmos Health (NASDAQ:COSM) announced its successful participation in Vitafoods Europe 2024, held from May 14 to May 16 at Palexpo, Switzerland. The event, a premier nutraceutical trade show, attracted over 20,000 attendees, more than 50 speakers, and 1,100+ exhibitors from 160+ countries. Cosmos Health showcased its Sky Premium Life nutraceuticals range, receiving significant interest and positive feedback from industry leaders and potential partners. The company connected with numerous organizations, exploring new trends and building partnerships to expand its global business network. CEO Greg Siokas highlighted the event's success in accelerating business growth and enhancing Cosmos Health's international presence.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.